These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30072631)

  • 21. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
    Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
    Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Pignot G; Le Goux C; Vacher S; Schnitzler A; Radvanyi F; Allory Y; Lallemand F; Delongchamps NB; Zerbib M; Terris B; Damotte D; Bieche I
    Oncol Lett; 2019 Oct; 18(4):3471-3480. PubMed ID: 31516565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Analysis of Differentially Mutated Genes in Non-Muscle and Muscle-Invasive Bladder Cancer in the Chinese Population by Whole Exome Sequencing.
    Wang F; Dong X; Yang F; Xing N
    Front Genet; 2022; 13():831146. PubMed ID: 35419031
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells.
    Olsson AY; Feber A; Edwards S; Te Poele R; Giddings I; Merson S; Cooper CS
    Oncogene; 2007 Feb; 26(7):1028-37. PubMed ID: 16909110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients.
    Singh R; Mandhani A; Agrawal V; Garg M
    Cancer Microenviron; 2018 Jun; 11(1):23-39. PubMed ID: 29349669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
    Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
    Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The therapeutic and prognostic implications of molecular biomarkers in urothelial carcinoma.
    Kang HW; Kim WJ; Yun SJ
    Transl Cancer Res; 2020 Oct; 9(10):6609-6623. PubMed ID: 35117271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bladder cancer stem cells: clonal origin and therapeutic perspectives.
    Li Y; Lin K; Yang Z; Han N; Quan X; Guo X; Li C
    Oncotarget; 2017 Sep; 8(39):66668-66679. PubMed ID: 29029546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex-related differences in urothelial cell carcinoma of the bladder in Germany.
    Scheller T; Hofmann R; Hegele A
    Cancer Manag Res; 2019; 11():309-316. PubMed ID: 30643456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ΔNp63 transcript loss in bladder cancer constitutes an independent molecular predictor of TaT1 patients post-treatment relapse and progression.
    Papadimitriou MA; Avgeris M; Levis PK; Tokas T; Stravodimos K; Scorilas A
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):3075-3087. PubMed ID: 31595333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.
    Cambier S; Sylvester RJ; Collette L; Gontero P; Brausi MA; van Andel G; Kirkels WJ; Silva FC; Oosterlinck W; Prescott S; Kirkali Z; Powell PH; de Reijke TM; Turkeri L; Collette S; Oddens J
    Eur Urol; 2016 Jan; 69(1):60-9. PubMed ID: 26210894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of stem cells markers and its effects on the propensity for recurrence and metastasis in bladder cancer: A systematic review.
    Hamid ARAH; Syadza YZ; Yausep OE; Christanto RBI; Muharia BHR; Mochtar CA
    PLoS One; 2023; 18(5):e0269214. PubMed ID: 37196048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of open chromatin regions in bladder cancer links β-catenin mutations and Wnt signaling with neuronal subtype of bladder cancer.
    Eray A; Güneri PY; Yılmaz GÖ; Karakülah G; Erkek-Ozhan S
    Sci Rep; 2020 Oct; 10(1):18667. PubMed ID: 33122695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1.
    Sathe G; George IA; Deb B; Jain AP; Patel K; Nayak B; Karmakar S; Seth A; Pandey A; Kumar P
    Oncotarget; 2020 Aug; 11(34):3244-3255. PubMed ID: 32922663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative bioinformatics analysis of prognostic and differentially expressed genes in non-muscle and muscle invasive bladder cancer.
    Silva TA; Azevedo H
    J Proteomics; 2020 Oct; 229():103951. PubMed ID: 32860965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fatty acid synthase, Her2/neu, and E2F1 as prognostic markers of progression in non-muscle invasive bladder cancer.
    Abdelrahman AE; Rashed HE; Elkady E; Elsebai EA; El-Azony A; Matar I
    Ann Diagn Pathol; 2019 Apr; 39():42-52. PubMed ID: 30684846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.
    Li R; Metcalfe MJ; Tabayoyong WB; Guo CC; Nogueras González GM; Navai N; Grossman HB; Dinney CP; Kamat AM
    Eur Urol Oncol; 2019 May; 2(3):286-293. PubMed ID: 31200843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive value of cadherin-11 for subsequent recurrence and progression in non-muscle invasive bladder cancer.
    Chen MK; Chen ZJ; Xiao KH; Qin ZK; Ye YL; Wen WJ; Bian J; Xue KY; Zhou QZ; Guo WB; Zhou JH; Xia M; Li X; Liu CD
    Jpn J Clin Oncol; 2020 Apr; 50(4):456-464. PubMed ID: 31894237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of SAM68 in the progression and prognosis for bladder cancer.
    Zhang Z; Yu C; Li Y; Jiang L; Zhou F
    BMC Cancer; 2015 May; 15():364. PubMed ID: 25944080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencing.
    Wang T; Liu Z; Wang X; Bai P; Sun A; Shao Z; Luo R; Wu Z; Zhang K; Li W; Xiao W; Duan B; Wang Y; Chen B; Xing J
    Cancer Biol Ther; 2020 Aug; 21(8):709-716. PubMed ID: 32449441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.